Osteoporosis and fusion
Kahanovitz, N.
Instructional Course Lectures 41: 231-233
1992
ISSN/ISBN: 0065-6895 PMID: 1588065 Document Number: 395481
Document emailed within 1 workday
Related Documents
Long, H.; Kazunasa, U.; Liu, S.; Akio, S.; Taito, I. 2007: Preliminary application of one-level posterior lumbar interbody fusion with prospace and facet fusion using local autograft Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21(11): 1155-1159Galante Romo, M.ía.I.; Ciappara Paniagua, M.; Moreno Sierra, J.ús. 2019: Fusion biopsy. Analysis of fusion software platforms Archivos Espanoles de Urologia 72(8): 794-803
Leufvén, C.; Nordwall, A. 1999: Management of chronic disabling low back pain with 360 degrees fusion. Results from pain provocation test and concurrent posterior lumbar interbody fusion, posterolateral fusion, and pedicle screw instrumentation in patients with chronic disabling low back pain Spine 24(19): 2042-2045
Kim, N.H.; Lee, J.W. 1999: Anterior interbody fusion versus posterolateral fusion with transpedicular fixation for isthmic spondylolisthesis in adults. A comparison of clinical results Spine 24(8): 812
Pongchaiyakul, C.; Wanothayaroj, E. 2007: Performance of the Khon Kaen Osteoporosis Study (KKOS) score for identifying osteoporosis in men Journal of the Medical Association of Thailand 90(8): 1518-1523
Zhu, Y.; Liu, H-ying.; Wang, B.; Wang, H-min.; Qian, Y-long.; Zhu, Z-qi.; Miao, K-nan. 2013: Long-term clinical outcomes of selective segmental transforaminal lumbar interbody fusion and posterior spinal fusion for degenerative lumbar scoliosis Zhonghua Yi Xue Za Zhi 93(45): 3577-3581
Robin, J.C.; Ambrus, J.L. 1982: Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis Research Communications in Chemical Pathology and Pharmacology 35(3): 491-498
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256
Zhang, X.; Lin, J.; Yang, X.; Fei, Q.; Wang, B.; Yang, Y.; Li, J.; Ma, Z.; Zhao, F.; Wang, Q. 2015: Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderly male Zhonghua Yi Xue Za Zhi 95(41): 3366-3369
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Ohgimoto, S.; Tabata, N.; Suga, S.; Nishio, M.; Ohta, H.; Tsurudome, M.; Komada, H.; Kawano, M.; Watanabe, N.; Ito, Y. 1995: Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules Journal of Immunology 155(7): 3585-3592
Wild, J. 1986: Gene fusion in studies on gene expression regulation and protein analysis. use of lac fusion Postepy Biochemii 32(4): 421-443
Spencer, H.; Kramer, L. 1986: NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis Journal of Nutrition 116(2): 316-319
Syc, S. 1971: Causes of cortisol-induced osteoporosis and Cushing's disease osteoporosis Wiadomosci Lekarskie 24(1): 41-43
Joseph, P.; Hughes, D. 1997: Osteoporosis. Guidelines for general practitioners. Osteoporosis Australia Australian Family Physician 26(10): 1181-5 1188-91 1194-6
Chang, S.Fang.; Yang, R.Sen. 2014: Determining the cut-off point of osteoporosis based on the osteoporosis self-assessment tool, body mass index and weight in Taiwanese young adult women Journal of clinical nursing 23(17-18): 2628-2635
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Tabata, N.; Yoshida, T.; Shiraishi, T.; Suga, S.; Tsurudome, M.; Ito, Y. 1995: Tissue distribution of fusion regulatory protein-1 and fusion regulatory protein-2 Archives of Pathology and Laboratory Medicine 119(5): 461-466
Mita, E.; Hayashi, N.; Kamada, T. 1995: Transactivation function of X gene-cellular gene fusion product or 3' truncated pre S2/S gene-cellular gene fusion product from integrated hepatitis B virus DNA Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 2): 89-93
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584